Getinge AB (GNGBY)
25.74
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Getinge Enterprise Value : 7.482B for Aug. 27, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 27, 2026 | 7.482B |
| August 26, 2026 | 7.482B |
| August 25, 2026 | 7.482B |
| August 24, 2026 | 7.482B |
| August 21, 2026 | 7.482B |
| August 20, 2026 | 7.497B |
| August 19, 2026 | 7.500B |
| August 18, 2026 | 7.337B |
| August 17, 2026 | 7.327B |
| August 14, 2026 | 7.333B |
| August 13, 2026 | 7.289B |
| August 12, 2026 | 7.289B |
| August 11, 2026 | 7.308B |
| August 10, 2026 | 7.337B |
| August 07, 2026 | 7.299B |
| August 06, 2026 | 7.284B |
| August 05, 2026 | 7.325B |
| August 04, 2026 | 7.335B |
| August 03, 2026 | 7.307B |
| July 31, 2026 | 7.261B |
| July 30, 2026 | 7.235B |
| July 29, 2026 | 7.195B |
| July 28, 2026 | 7.103B |
| July 27, 2026 | 6.942B |
| July 24, 2026 | 6.943B |
| Date | Value |
|---|---|
| July 23, 2026 | 6.891B |
| July 22, 2026 | 7.031B |
| July 21, 2026 | 7.017B |
| July 20, 2026 | 7.012B |
| July 17, 2026 | 7.086B |
| July 16, 2026 | 6.455B |
| July 15, 2026 | 6.412B |
| July 14, 2026 | 6.356B |
| July 13, 2026 | 6.412B |
| July 10, 2026 | 6.399B |
| July 09, 2026 | 6.285B |
| July 08, 2026 | 6.178B |
| July 07, 2026 | 6.336B |
| July 06, 2026 | 6.333B |
| July 02, 2026 | 6.283B |
| July 01, 2026 | 6.227B |
| June 30, 2026 | 6.107B |
| June 29, 2026 | 5.892B |
| June 26, 2026 | 5.881B |
| June 25, 2026 | 5.936B |
| June 24, 2026 | 5.811B |
| June 23, 2026 | 5.763B |
| June 22, 2026 | 5.812B |
| June 18, 2026 | 5.874B |
| June 17, 2026 | 5.842B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Xvivo Perfusion AB | 955.97M |
| Paxman AB | 71.82M |
| Enovis Corp. | 2.790B |
| Edwards Lifesciences Corp. | 48.42B |
| Intuitive Surgical, Inc. | 124.79B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 89.59M |
| Revenue (Quarterly) | 894.98M |
| Total Expenses (Quarterly) | 805.18M |
| EPS Diluted (Quarterly) | 0.3297 |
| Gross Profit Margin (Quarterly) | 49.35% |
| Profit Margin (Quarterly) | 10.01% |
| Earnings Yield | 4.07% |
| Operating Earnings Yield | 7.06% |
| Normalized Earnings Yield | 4.253 |